Evaluate effectiveness of desensitizing agents in the treatment of dental sensitivity.
Phase 2
- Conditions
- Health Condition 1: K038- Other specified diseases of hard tissues of teeth
- Registration Number
- CTRI/2023/06/054170
- Lead Sponsor
- Institute of Dental Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients within the age range of 25â??65 years with wasting diseases and/or gingival recession.
Patients having no fewer than 2 sensitive permanent dental surfaces (incisor, canine, or premolar buccal/facial aspects).
Patients with pain having Visual Analogue Score >=4.
Exclusion Criteria
Patients who have undergone periodontal treatment in last six months.
Pregnant or nursing females.
Patients who have dental caries and grossly decayed teeth i.e involving pulp.
Negative behaviours include drinking alcohol or smoking.
Antibiotic use in the six months before to the study.
Systemic diseases.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the efficacy of BioMin, NovaMin, Syzygium aromaticum, strontium chloride hexahydrate & potassium nitrate in treatment of dentinal hypersensitivity.Timepoint: 0 2 4 & 6 weeks
- Secondary Outcome Measures
Name Time Method To inter-compare the efficacy of BioMin, NovaMin, Syzygium aromaticum, strontium chloride hexahydrate & potassium nitrate in the treatment of dentinal hypersensitivity.Timepoint: 0 2 4 & 6 weeks